Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ylenia Dal Bosco
Observed names:
Dal Bosco Ylenia,
Y Dal Bosco,
Y. Dal Bosco,
Ylenia DAL BOSCO,
Ylenia dal Bosco
Institutions:
University of Catania,
Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco"
Observed institutions:
Università Cattolica del Sacro Cuore,
Pfizer (United States),
University of Catania,
Policlinico Universitario di Catania,
Ospedale Cannizzaro,
Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco"
show all 6
ORCID:
0000-0002-7233-6369
Observed ORCID:
0000-0002-7233-6369
OpenAlex ID:
A5071889618
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups
2021
·
Clodoveo Ferri
, Francesco Ursini
, et al.
·
Journal of Autoimmunity
·
117
PDF
Clinical and Histopathological Features of Scleroderma-like Disorders: An Update
2021
·
Rosario Foti
, Rocco De Pasquale
, et al.
·
Medicina
·
21
PDF
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases
2022
·
Clodoveo Ferri
, Laura Gragnani
, et al.
·
Journal of Autoimmunity
·
20
Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study
2022
·
Roberta Ramonda
, Mariagrazia Lorenzin
, et al.
·
Therapeutic Advances in Musculoskeletal Disease
·
19
Present and future of biologic drugs in primary Sjögren’s syndrome
2016
·
Domenico Sambataro
, Gianluca Sambataro
, et al.
·
Expert Opinion on Biological Therapy
·
19
Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort Study
2023
·
Marino Paroli
, Andrea Becciolini
, et al.
·
Medicina
·
15
PDF
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments
2021
·
Clodoveo Ferri
, Dilia Giuggioli
, et al.
·
Current Pharmaceutical Design
·
15
PDF
Guselkumab in Psoriatic Arthritis: Therapeutic Impact on Axial and Peripheral Involvement—Monocentric Real-World Evidence
2025
·
Roberta Foti
, Giorgio Amato
, et al.
·
Journal of Clinical Medicine
·
14
PDF
Influence of Safety Warnings on the Prescribing Attitude of JAK Inhibitors for Rheumatoid Arthritis in Italy
2024
·
Marino Paroli
, Andrea Becciolini
, et al.
·
Journal of Clinical Medicine
·
13
PDF
Heart Valve Abnormalities in Systemic Sclerosis Patients
2020
·
Michele Colaci
, Claudia Schinocca
, et al.
·
JCR Journal of Clinical Rheumatology
·
13
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase
2023
·
Clodoveo Ferri
, Vincenzo Raimondo
, et al.
·
Journal of Translational Autoimmunity
·
10
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies
2022
·
Clodoveo Ferri
, Vincenzo Raimondo
, et al.
·
Current Pharmaceutical Design
·
9
Telemedicine in the Management of Patients with Rheumatic Disease during COVID-19 Pandemic: Incidence of Psychiatric Disorders and Fibromyalgia in Patients with Rheumatoid Arthritis and Psoriatic Arthritis
2022
·
Rosario Foti
, Giorgio Amato
, et al.
·
International Journal of Environmental Research and Public Health
·
9
PDF
Heart Valve Abnormalities in Systemic Sclerosis Patients: A Multicenter Cohort Study and Review of the Literature.
2022
·
Michele Colaci
, Claudia Schinocca
, et al.
·
PubMed
·
9
Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup—A Multicenter Study
2024
·
Marta Priora
, Andrea Becciolini
, et al.
·
Medicina
·
8
PDF
Analysis of survival rate and persistence predictors of baricitinib in real-world data from a large cohort of rheumatoid arthritis patients
2024
·
Simone Parisi
, Becciolini Andrea
, et al.
·
Current Research in Pharmacology and Drug Discovery
·
8
PDF
Effectiveness and safety of filgotinib in rheumatoid arthritis: a real-life multicentre experience
2023
·
Lidia La Barbera
, Chiara Rizzo
, et al.
·
Clinical and Experimental Rheumatology
·
7
PDF
Aortic root dilation in associated with the reduction in capillary density observed at nailfold capillaroscopy in SSc patients
2020
·
Michele Colaci
, Ylenia Dal Bosco
, et al.
·
Clinical Rheumatology
·
7
Multidisciplinary Rheuma–Derma Clinics: 5 Years of Experience at the San Marco Hospital in Catania
2022
·
Rosario Foti
, Giorgia Giuffrida
, et al.
·
Dermatology and Therapy
·
5
PDF
Umbilical Cord Blood-Derived Products in Autoimmune Systemic Syndromes with Severe Dryness: A Pilot Study
2024
·
Rosario Foti
, Marco Zeppieri
, et al.
·
Medicina
·
4
PDF
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis
2024
·
Alberto LO GULLO
, Simone PARISI
, et al.
·
Minerva Medica
·
4
Therapeutic Effects of Apremilast on Enthesitis and Dactylitis in Real Clinical Setting: An Italian Multicenter Study
2023
·
Alberto Lo Gullo
, Andrea Becciolini
, et al.
·
Journal of Clinical Medicine
·
4
PDF
Is there any role for thoracic ultrasound for interstitial lung disease underlying rheumatologic conditions?
2017
·
Domenico Sambataro
, Gianluca Sambataro
, et al.
·
Internal and Emergency Medicine
·
4
Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter Study
2025
·
Camilla Mazzanti
, Marino Paroli
, et al.
·
Journal of Psoriasis and Psoriatic Arthritis
·
3
Intravenous iloprost in systemic sclerosis and its effect in cardiopulmonary function: a retrospective observational study.
2022
·
R Foti
, G Amato
, et al.
·
PubMed
·
3
Show more works
View as search
Works count:
50
Citation count:
374
H-index:
10
I10-index:
11
Year
Topic
Type